2024-02-01 2025-01-31 false Capium Accounts Production 1.1 SC468004 2024-02-01 2025-01-31 SC468004 bus:AbridgedAccounts 2024-02-01 2025-01-31 SC468004 bus:FRS102 2024-02-01 2025-01-31 SC468004 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 SC468004 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 SC468004 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 SC468004 2024-02-01 2025-01-31 SC468004 2025-01-31 SC468004 bus:RegisteredOffice 2024-02-01 2025-01-31 SC468004 core:WithinOneYear 2025-01-31 SC468004 core:AfterOneYear 2025-01-31 SC468004 1 2024-02-01 2025-01-31 SC468004 bus:Director1 2024-02-01 2025-01-31 SC468004 bus:Director1 2025-01-31 SC468004 bus:Director1 2023-02-01 2024-01-31 SC468004 2023-02-01 SC468004 bus:LeadAgentIfApplicable 2024-02-01 2025-01-31 SC468004 2023-02-01 2024-01-31 SC468004 2024-01-31 SC468004 core:WithinOneYear 2024-01-31 SC468004 core:AfterOneYear 2024-01-31 SC468004 bus:EntityAccountantsOrAuditors 2023-02-01 2024-01-31 SC468004 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 SC468004 bus:OrdinaryShareClass1 2025-01-31 SC468004 bus:OrdinaryShareClass1 2023-02-01 2024-01-31 SC468004 bus:OrdinaryShareClass1 2024-01-31 SC468004 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 SC468004 core:CostValuation core:Non-currentFinancialInstruments 2024-01-31 SC468004 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-01-31 SC468004 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 SC468004 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 SC468004 core:Non-currentFinancialInstruments 2025-01-31 SC468004 core:Non-currentFinancialInstruments 2024-01-31 SC468004 core:ShareCapital 2025-01-31 SC468004 core:ShareCapital 2024-01-31 SC468004 core:RetainedEarningsAccumulatedLosses 2025-01-31 SC468004 core:RetainedEarningsAccumulatedLosses 2024-01-31 SC468004 dpl:Item1 2024-02-01 SC468004 dpl:Item1 2025-01-31 SC468004 dpl:Item1 2023-02-01 SC468004 dpl:Item1 2024-01-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: SC468004
Scotland
MATRIX MEDICAL LIMITED
Abridged Accounts
Period of accounts Start date: 01 February 2024 End date: 31 January 2025

Matrix Medical Limited Contents Page For the year ended 31 January 2025
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

Matrix Medical Limited Accountants' Report For the year ended 31 January 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 31 January 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. County Business Services Limited 31 January 2025 .................................................... County Business Services Limited 438 Streatham High Road Streatham London SW16 3PX 01 November 2025 1

Matrix Medical Limited Statement of Financial Position As at 31 January 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Current assets |  |  |
Debtors: amounts falling due within one year |  | 0 |  | 9,743
Debtors: amounts falling due after one year |  | 14,300 |  | 0
Cash at bank and in hand |  | 3,244 |  | 11,616
|  | 17,544 |  | 21,359
Creditors: amount falling due within one year |  | (16,994) |  | (20,440)
Net current assets |  | 550 |  | 919
Total assets less current liabilities |  | 550 |  | 919
Net assets |  | 550 |  | 919
Capital and reserves |  |  |
Called up share capital | 3 | 100 |  | 100
Profit and loss account |  | 450 |  | 819
Shareholders' funds |  | 550 |  | 919
For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 01 November 2025 and were signed by:
------------------------------- Imran Sarfraz Director
2

Matrix Medical Limited Notes to the Abridged Financial Statements For the year ended 31 January 2025
General Information Matrix Medical Limited is a private company, limited by shares, registered in Scotland, registration number SC468004, registration address 16 Raeside Way, Maidenhill , Newton Mearns, G77 6YL. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2. | Average number of employees Average number of employees during the year was 2 (2024 : 1).
3. | Share Capital
Allotted, called up and fully paid | 2025 £ |  | 2024 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
3